Leap Therapeutics Inc (LPTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Leap Therapeutics Inc (LPTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7137
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, biliary tract cancer, hepatocellular carcinoma, and non-small cell lung cancer; and TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is in Phase 1 clinical trials intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc (LPTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leap Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Leap Therapeutics Inc, Medical Equipment, Deal Details 10
Merger 10
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Equity Offering 11
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Acquisition 14
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc – Key Competitors 16
Leap Therapeutics Inc – Key Employees 17
Leap Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Leap Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leap Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc, Key Competitors 16
Leap Therapeutics Inc, Key Employees 17
Leap Therapeutics Inc, Subsidiaries 18

List of Figures
Leap Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Leap Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Leap Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Leap Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Leap Therapeutics Inc (LPTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Omega Pharma NV:企業の戦略的SWOT分析
    Omega Pharma NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • United Biscuits (UK) Ltd:企業の戦略・SWOT・財務分析
    United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • RWE AG (RWE):電力:M&Aディール及び事業提携情報
    Summary RWE AG (RWE) is an energy company. It has presence in the energy value chain, from lignite production and electricity generation, to energy trading and operation of distribution networks, and supply of electricity, gas and energy solutions. The company produces electricity using conventional …
  • ITOCHU Corporation:企業の戦略・SWOT・財務分析
    ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report Summary ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Western Union Company:企業のM&A・事業提携・投資動向
    The Western Union Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Western Union Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Mitsubishi Gas Chemical Co Inc (4182):企業の財務・戦略的SWOT分析
    Mitsubishi Gas Chemical Co Inc (4182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Azul SA (AZUL4):企業の財務・戦略的SWOT分析
    Azul SA (AZUL4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Forma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forma Therapeutics Inc (Forma) is a drug discovery and development company that discovers and develops new transformative cancer therapeutics. The company develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor met …
  • Abu Dhabi National Hotels Company:企業の戦略・SWOT・財務分析
    Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Calumet Specialty Products Partners LP (CLMT):石油・ガス:M&Aディール及び事業提携情報
    Summary Calumet Specialty Products Partners LP (Calumet) is a downstream energy company that produces specialty hydrocarbon and fuel products. It processes crude oil and other feedstock into a wide range of solvents, lubricating oils, white mineral oils, petrolatums and waxes; and into fuel and fuel …
  • UNeMed Corp-製薬・医療分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • Ansell Limited (ANN):医療機器:M&Aディール及び事業提携情報
    Summary Ansell Limited (Ansell) is a provider of protection solutions. It develops, manufactures and markets a broad range of hand and arm protection solutions and hospital clothing. It also offers medical gloves and healthcare and industrial safety solutions. Ansell offers its products to healthcar …
  • Aerovironment Inc:企業の戦略・SWOT・財務分析
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …
  • Thien Viet Securities Joint Stock Company:企業の戦略的SWOT分析
    Thien Viet Securities Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務情報
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • Bilfinger SE (GBF)-エネルギー分野:企業M&A・提携分析
    Summary Bilfinger SE (Bilfinger) is one of the leading global engineering and services companies in the world. It offers a wide range of design, construction, maintenance, engineering, consulting, and project management services across diverse end markets. The company’s major service offerings inclu …
  • Oki Electric Industry Co., Ltd. (6703):企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆